Science揭秘:这种胆固醇,让肝脏疾病有救了!

2021-08-13 zyyzjy MedSci原创

最新发表在《Science》杂志上一篇研究显示小肠分泌的HDL3可通过阻断肠道细菌产生的炎症反应来发挥肝脏保护作用。

高密度脂蛋白(HDL)胆固醇是公认的“好胆固醇”,既往的大量研究显示其可降低血管疾病的风险。尽管近些年几种升高HDL-C的药物实验结果并没有显示硬终点获益,其“好胆固醇”的称号遭受了一些质疑和挑战,但仍陆续有研究结果为其正名。  

最新发表在《Science》杂志上一篇研究显示小肠分泌的HDL3可通过阻断肠道细菌产生的炎症反应来发挥肝脏保护作用。

 
图片

此项研究中圣路易斯的华盛顿大学医学院的研究者通过荧光标记小鼠肠源性HDL3,发现HDL3主要由回肠分泌,分泌后并不像其他乳糜微粒那样进入淋巴管,而是迅速进入门静脉,与其内的脂多糖结合蛋白(LBP)结合,阻止肠道损伤引起的革兰氏阴性细菌分泌的脂多糖激活枯否细胞,从而抑制炎症反应,保护肝脏免受炎症及纤维化的损伤。

 
图片

Enterically derived high-density lipoprotein restrains liver injury through the portal vein. Science 373, 410 (2021) 23.doi.org/10.1126/science.abe6729  

研究者尝试将小鼠部分小肠切除(50%或75%的小肠,保留小肠近端部分和回肠末端),结果显示门静脉内LPS生物活性升高,肝损伤加重。原因可能与更短的肠道使HDL3产生减少,同时手术本身会导致肠道的损伤产生更多的脂多糖有关。  

此外研究者给予小鼠口服低剂量GW3965(一种LXRs激动剂,LXRs是控制HDL相关基因表达的转录因子),结果显示其可保护肝脏免受炎症和纤维化影响,此作用取决于其增加肠道HDL分泌的能力。

而在人体中,儿科专家发现一些早产儿因坏死性小肠结肠炎行手术切除一部分肠道后经常会患上肝病,动物实验的结果也许能给予一部分解释

基于上述实验发现,HDL有望成为今后肝损伤治疗的一个新的方向。

 
图片

health.harvard

除了心血管、肝脏的保护作用外,研究显示HDL对肾脏、脑、肺脏、内分泌系统同样发挥保护作用。

 

肾病综合征患者的血清HDL-c水平通常在正常范围内或以下,HDL-c缺乏会导致极低密度脂蛋白和乳糜微粒代谢障碍,限制脂质向肌细胞输送以产生能量和向脂肪组织输送以储存能量。HDL功能障碍还可导致肾脏动脉粥样硬化和促炎的乳糜微粒残留、异常LDL颗粒的积累。巨噬细胞和肾小球系膜细胞摄取这些异常脂蛋白,会加速动脉粥样硬化和肾小球硬化。  

同样,在慢性肾病和终末期肾病患者中HDL-c水平也会显著降低并出现功能障碍,失去其抗氧化应激、抗炎、保护内皮功能等功能,从而加速患者肾脏疾病的进展。

 
图片

HDL abnormalities in nephrotic syndrome and chronic kidney disease. Nat Rev Nephrol 2016,12(1):37-47. doi:10.1038/nrneph.2015.180.

胆固醇是哺乳动物的外周和中枢神经系统的重要组成部分。中枢神经系统中HDL的主要载脂蛋白成分是载脂蛋白E,由星形胶质细胞和小胶质细胞产生。低HDL-C水平与认知障碍和各种神经退行性疾病有关。

HDL的抗氧化和抗炎特性可影响大脑中的炎症反应。HDL介导的胆固醇反向转运可降低脑血管的动脉粥样硬化负担,从而抑制血管性痴呆的进展。HDL对内皮功能的保护作用可影响脑血管功能,影响神经元活动,从而发挥脑保护作用,减少多种神经系统疾病的发生发展。

 

图片

 

HDL AND CHOLESTEROL HANDLING IN THE BRAIN. Cardiovasc Res 2014, 103(3):405-13.

代谢

HDL及其主要载脂蛋白A-I (ApoA-I)现已被证实通过多种机制影响糖代谢。临床研究发现T2DM患者中,无论是通过短期重组HDL输注引起的急性HDL升高,还是通过胆固醇酯转移蛋白(CETP)抑制剂引起的慢性HDL升高,都能降低血糖。HDL可能通过不同的机制在多个器官(如胰腺、骨骼肌、心脏、脂肪、肝脏、大脑)的作用下介导对葡萄糖代谢的影响:(i)胰腺β细胞分泌胰岛素(ii)胰岛素非依赖性葡萄糖摄取(iii)胰岛素敏感性。

 

图片

HDL and glucose metabolism: current evidence and therapeutic potential. Front Pharmacol, 2015,6:258. doi: 10.3389/fphar.2015.00258.

人体检测显示脓毒症所致ARDS患者血浆中HDL-C和HDL-载脂蛋白(apoA-I、apoA-II、apoA-IV、pak - iii)水平较健康对照者明显降低,且HDL组分也发生了显著变化。体内研究表明,ARDS大鼠的HDL加重了脓毒症所致的ALI,提示HDL在脓毒症性ARDS过程中发生了不良功能转变。而这些有害作用与肺内皮功能障碍有关,而肺与LPS增加有关。这些研究结果揭示了HDL成分的重塑使内皮功能障碍导致脓毒症性ARDS的发生,也证明了循环HDL在调节肺泡内稳态中的重要性。

 

图片

The HDL from septic-ARDS patients with composition changes exacerbates pulmonary endothelial dysfunction and acute lung injury induced by cecal ligation and puncture (CLP) in mice.. Respir Res (2020) 21:293 .doi.org/10.1186/s12931-020-01553-3.

肿瘤

除脏器保护作用之外,一些观察性研究显示HDL-C水平降低与多种癌症相关包括结直肠癌、肺癌、乳腺癌卵巢癌、甲状腺癌、胃癌等。高HDL-水平与大多数肿瘤类型的OS和DFS呈正相关,与死亡率呈负相关。一些研究甚至表明,HDL-C可以作为某些癌症患者的预后标志物。

一项涉及145万参与者的荟萃分析显示HDL-C和癌症风险之间呈J形关联,当HDL-C水平为64-68 mg/dL时,癌症风险最低。

此结果表明两者并非呈线性关系,可能存在多种影响因素,年龄、性别、疾病阶段、肿瘤类型和许多其他因素(如癌症治疗方式、氧化应激等)等,需进一步的研究确定。

 

图片

HDL and cancer - causality still needs to be confirmed? Update 2020.Semin Cancer Biol 2021, 73:169-177. doi.org/10.1016/j.semcancer.2020.10.007.

HDL对多个脏器、多种疾病均有保护作用,未来我们可能会发现更多它的好。

 

参考文献:

1.Enterically derived high-density lipoprotein restrains liver injury through the portal vein. Science 373, 410 (2021) 23.doi.org/10.1126/science.abe6729

2.HDL abnormalities in nephrotic syndrome and chronic kidney disease. Nat Rev Nephrol 2016,12(1):37-47. doi:10.1038/nrneph.2015.180.

3.HDL and cholesterol handling in the brain. Cardiovascular Research, 2014,103(3), 405–413. doi:10.1093/cvr/cvu148

4.HDL and glucose metabolism: current evidence and therapeutic potential. Front Pharmacol, 2015,6:258. doi: 10.3389/fphar.2015.00258.

5.The HDL from septic-ARDS patients with composition changes exacerbates pulmonary endothelial dysfunction and acute lung injury induced by cecal ligation and puncture (CLP) in mice.. Respir Res (2020) 21:293 .doi.org/10.1186/s12931-020-01553-3.

6.HDL and cancer - causality still needs to be confirmed? Update 2020.Semin Cancer Biol 2021, 73:169-177. doi.org/10.1016/j.semcancer.2020.10.007.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1253396, encodeId=19831253396bf, content=<a href='/topic/show?id=12c98145216' target=_blank style='color:#2F92EE;'>#肝脏疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81452, encryptionId=12c98145216, topicName=肝脏疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Sun Aug 15 00:16:30 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376335, encodeId=acf113e633577, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sun Aug 15 00:16:30 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007788, encodeId=eca3100e78868, content=已读已读已读已读已读已读,学学习学习学习学习学习学习。受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sat Aug 14 09:31:16 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007766, encodeId=690b100e76685, content=学习了,怎么提高, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/e9408422a23545ef9738dd674abfc4ff/c719925083844b82986bc39d43051172.jpg, createdBy=8eb14795142, createdName=与狼共舞, createdTime=Sat Aug 14 06:09:35 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007660, encodeId=9c80100e660a2, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2985457465, createdName=ms7000000052341924, createdTime=Fri Aug 13 16:34:01 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007562, encodeId=59dd100e56279, content=学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/201b0ea75d294b86b28303c6958f3a36/9507d8a00c3d454ab9aa4079d1ed61a8.jpg, createdBy=da265452624, createdName=河池名医, createdTime=Fri Aug 13 11:15:18 CST 2021, time=2021-08-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1253396, encodeId=19831253396bf, content=<a href='/topic/show?id=12c98145216' target=_blank style='color:#2F92EE;'>#肝脏疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81452, encryptionId=12c98145216, topicName=肝脏疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Sun Aug 15 00:16:30 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376335, encodeId=acf113e633577, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sun Aug 15 00:16:30 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007788, encodeId=eca3100e78868, content=已读已读已读已读已读已读,学学习学习学习学习学习学习。受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sat Aug 14 09:31:16 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007766, encodeId=690b100e76685, content=学习了,怎么提高, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/e9408422a23545ef9738dd674abfc4ff/c719925083844b82986bc39d43051172.jpg, createdBy=8eb14795142, createdName=与狼共舞, createdTime=Sat Aug 14 06:09:35 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007660, encodeId=9c80100e660a2, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2985457465, createdName=ms7000000052341924, createdTime=Fri Aug 13 16:34:01 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007562, encodeId=59dd100e56279, content=学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/201b0ea75d294b86b28303c6958f3a36/9507d8a00c3d454ab9aa4079d1ed61a8.jpg, createdBy=da265452624, createdName=河池名医, createdTime=Fri Aug 13 11:15:18 CST 2021, time=2021-08-13, status=1, ipAttribution=)]
    2021-08-15 jichang
  3. [GetPortalCommentsPageByObjectIdResponse(id=1253396, encodeId=19831253396bf, content=<a href='/topic/show?id=12c98145216' target=_blank style='color:#2F92EE;'>#肝脏疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81452, encryptionId=12c98145216, topicName=肝脏疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Sun Aug 15 00:16:30 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376335, encodeId=acf113e633577, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sun Aug 15 00:16:30 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007788, encodeId=eca3100e78868, content=已读已读已读已读已读已读,学学习学习学习学习学习学习。受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sat Aug 14 09:31:16 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007766, encodeId=690b100e76685, content=学习了,怎么提高, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/e9408422a23545ef9738dd674abfc4ff/c719925083844b82986bc39d43051172.jpg, createdBy=8eb14795142, createdName=与狼共舞, createdTime=Sat Aug 14 06:09:35 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007660, encodeId=9c80100e660a2, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2985457465, createdName=ms7000000052341924, createdTime=Fri Aug 13 16:34:01 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007562, encodeId=59dd100e56279, content=学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/201b0ea75d294b86b28303c6958f3a36/9507d8a00c3d454ab9aa4079d1ed61a8.jpg, createdBy=da265452624, createdName=河池名医, createdTime=Fri Aug 13 11:15:18 CST 2021, time=2021-08-13, status=1, ipAttribution=)]
    2021-08-14 ms5000000518166734

    已读已读已读已读已读已读,学学习学习学习学习学习学习。受益匪浅

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1253396, encodeId=19831253396bf, content=<a href='/topic/show?id=12c98145216' target=_blank style='color:#2F92EE;'>#肝脏疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81452, encryptionId=12c98145216, topicName=肝脏疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Sun Aug 15 00:16:30 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376335, encodeId=acf113e633577, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sun Aug 15 00:16:30 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007788, encodeId=eca3100e78868, content=已读已读已读已读已读已读,学学习学习学习学习学习学习。受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sat Aug 14 09:31:16 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007766, encodeId=690b100e76685, content=学习了,怎么提高, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/e9408422a23545ef9738dd674abfc4ff/c719925083844b82986bc39d43051172.jpg, createdBy=8eb14795142, createdName=与狼共舞, createdTime=Sat Aug 14 06:09:35 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007660, encodeId=9c80100e660a2, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2985457465, createdName=ms7000000052341924, createdTime=Fri Aug 13 16:34:01 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007562, encodeId=59dd100e56279, content=学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/201b0ea75d294b86b28303c6958f3a36/9507d8a00c3d454ab9aa4079d1ed61a8.jpg, createdBy=da265452624, createdName=河池名医, createdTime=Fri Aug 13 11:15:18 CST 2021, time=2021-08-13, status=1, ipAttribution=)]
    2021-08-14 与狼共舞

    学习了,怎么提高

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1253396, encodeId=19831253396bf, content=<a href='/topic/show?id=12c98145216' target=_blank style='color:#2F92EE;'>#肝脏疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81452, encryptionId=12c98145216, topicName=肝脏疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Sun Aug 15 00:16:30 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376335, encodeId=acf113e633577, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sun Aug 15 00:16:30 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007788, encodeId=eca3100e78868, content=已读已读已读已读已读已读,学学习学习学习学习学习学习。受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sat Aug 14 09:31:16 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007766, encodeId=690b100e76685, content=学习了,怎么提高, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/e9408422a23545ef9738dd674abfc4ff/c719925083844b82986bc39d43051172.jpg, createdBy=8eb14795142, createdName=与狼共舞, createdTime=Sat Aug 14 06:09:35 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007660, encodeId=9c80100e660a2, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2985457465, createdName=ms7000000052341924, createdTime=Fri Aug 13 16:34:01 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007562, encodeId=59dd100e56279, content=学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/201b0ea75d294b86b28303c6958f3a36/9507d8a00c3d454ab9aa4079d1ed61a8.jpg, createdBy=da265452624, createdName=河池名医, createdTime=Fri Aug 13 11:15:18 CST 2021, time=2021-08-13, status=1, ipAttribution=)]
    2021-08-13 ms7000000052341924

    学习了!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1253396, encodeId=19831253396bf, content=<a href='/topic/show?id=12c98145216' target=_blank style='color:#2F92EE;'>#肝脏疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81452, encryptionId=12c98145216, topicName=肝脏疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Sun Aug 15 00:16:30 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376335, encodeId=acf113e633577, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sun Aug 15 00:16:30 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007788, encodeId=eca3100e78868, content=已读已读已读已读已读已读,学学习学习学习学习学习学习。受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sat Aug 14 09:31:16 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007766, encodeId=690b100e76685, content=学习了,怎么提高, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/e9408422a23545ef9738dd674abfc4ff/c719925083844b82986bc39d43051172.jpg, createdBy=8eb14795142, createdName=与狼共舞, createdTime=Sat Aug 14 06:09:35 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007660, encodeId=9c80100e660a2, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2985457465, createdName=ms7000000052341924, createdTime=Fri Aug 13 16:34:01 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007562, encodeId=59dd100e56279, content=学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/201b0ea75d294b86b28303c6958f3a36/9507d8a00c3d454ab9aa4079d1ed61a8.jpg, createdBy=da265452624, createdName=河池名医, createdTime=Fri Aug 13 11:15:18 CST 2021, time=2021-08-13, status=1, ipAttribution=)]
    2021-08-13 河池名医

    学习!

    0

相关资讯

Circulation:含有apoC-III的HDL亚型或可增加心血管意外的风险!

有遗传和随机性研究均对高密度脂蛋白(HDL)胆固醇在心脏保护中的作用发出质疑。新的与HDL功能相关的检测方法或许可为预测心血管意外风险提供新的信息。载脂蛋白C-III(apoC-III)是脂蛋白代谢的关键调控因子。Majken K. Jensen等人对由apoC-III定义的HDL亚型是否与冠心病(CHD)相关进行探究。

JAHA:心力衰竭患者高密度脂蛋白功能受损

基线时更好的HDL胆固醇外流与随访期间较低的死亡率相关,而与HDL胆固醇无关。心力衰竭患者随访期间HDL胆固醇外流和抗炎能力下降。

J Lipid Res:CKD患者采用HDL预测心血管疾病风险并不可靠

近日,在线发表于《The Journal of Lipid Research》杂志上的一项研究表明,在慢性肾脏病(CKD)患者中,高密度脂蛋白(HDL)并不能预测患者今后的心血管疾病风险。

Circulation:HDL-P与缺血性事件的相关性分析:大样本、多种族、多器官、不同性别

高密度脂蛋白胆固醇是一种公认的动脉粥样硬化保护性标志物,特别是冠心病;然而,HDL颗粒浓度或可能更好地预测心血管疾病风险。本研究旨在对比HDL-C和HDL-P与不同特征人群动粥心血管疾病风险的相关性

JACC:高密度脂蛋白颗粒与心衰预后相关

循环血中的高密度脂蛋白颗粒(HDL-P)会影响动脉粥样硬化、炎症和内皮的功能,而这些过程均与心衰的发生有关。本研究的目的旨在比较和评估决定心衰伴射血分数减少(HFrEF )的患者和心衰伴保留型射血分数(HFpEF)患者预后的HDL-P差异。本研究纳入了CATHGEN临床研究中的782名HFrEF 患者,1004名HFpEF患者和4742名无心衰患者,分析结果显示,HFrEF 患者的平均HDL-P颗

美国临床营养杂志:吃牛肉可以降低患心脏病风险?

食用低饱和脂肪地中海饮食、和500g/周的未加工瘦红肉,5周后,可降低总胆固醇与低密度脂蛋白胆固醇

拓展阅读

JCEM:HDL颗粒亚型及其与2型糖尿病之间的关联

较大HDL颗粒且较低H2P含量与较低T2D风险相关,而较高H2P水平与较高的T2D风险相关。此外,在非肥胖受试者中,较大的HDL颗粒和H6P与T2D风险呈负相关。

JAHA:HDL抗炎功能、心血管疾病和死亡风险

在以慢性炎症为基础招募的JUPITER参与者中,HII与心血管疾病/死亡率有关,其最佳抗炎HII范围为0.5至1.0。HDL抗炎功能与心血管疾病/死亡风险之间的这种非线性关系可能部分解释了HDL悖论。

J Hepatology: HDL相关生物标志物是慢性肝衰竭患者生存的有力预测指标

急性代偿失调(AD)的发生会恶化晚期慢性肝病(ACLD)的预后,导致全身性炎症增加,以及急性慢性肝功能衰竭(ACLF),短期死亡率急剧上升。在败血症等急性病中,高密度脂蛋白胆固醇(HDL-C)含量迅速下降,HDL颗粒的组成和功能发生深刻变化。因此,HDL数量和质量的指标可能与晚期肝病患者的进展和生存有关。本项研究对此进行了相关研究。

Circulation:HDL功能失调与心血管高危人群急性冠脉综合征发病率增高相关

研究尚未能在高密度脂蛋白胆固醇(HDL)和心血管疾病之间建立明确的联系,这导致了一种假设,即HDL的动脉粥样硬化保护作用在于其生物活性,而不是其胆固醇含量。但迄今为止,HDL功能特性与急性冠状动脉综合征之间的关系还没有得到全面的研究。研究人员在PREDIMED队列中进行了一项嵌套的病例对照研究,该队列最初是一项随机试验,受试者遵循地中海式或低脂饮食。招募了167位急性冠脉综合征病例,评估了两项表现

J Hepatology:法尼醇X受体激动剂对非酒精性脂肪性肝炎患者脂蛋白谱的影响

法尼醇X受体激动剂奥贝胆酸(OCA)可增加非酒精性脂肪性肝炎患者的总脂蛋白胆固醇和低密度脂蛋白胆固醇(LDL-C)的含量。在本研究中,研究人员旨在评估OCA治疗对脂蛋白亚颗粒的影响。

Lancet:非高密度脂蛋白胆固醇浓度与长期心血管事件风险

非高密度脂蛋白胆固醇浓度与动脉粥样硬化性心血管疾病的长期风险密切相关,研究为个体长期风险评估和早期降脂干预的潜在益处提供了一个简单的工具